Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ELK Biotechnology is a high-tech enterprise headquartered in Wuhan, China, that specializes in the development and manufacturing of life science reagents. The company provides a vast portfolio of products, including over 10,000 ELISA kits, 10,000 antibodies, and a wide range of molecular biology reagents and proteins. Beyond its product catalog, ELK Biotechnology offers contract research services such as antibody production, protein expression, and gene synthesis to support global researchers. Their offerings are utilized across various fields including immunology, oncology, and cell biology. The company maintains a strong focus on quality control and technical support to facilitate advancements in basic research and clinical diagnostics. Their products are distributed globally to academic institutions, biotechnology companies, and pharmaceutical laboratories.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ELK Biotechnology.